| Followers | 53 |
| Posts | 14438 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Thursday, November 25, 2021 9:56:44 AM
Canes, I agree with you about the shoddy judicial work done by Amarin's legal team, no question.
Some days, I too would just like to wake up to selling the whole shebang at 10 and get on with what is remaining of life after wasting so many years with this.
But I have to say I have a different recollection of JL. Of course back in those days he was a prolific poster here so it is possible that he had one post out of hundreds where he wanted to throw in the towel, but you can see from these posts, just before and after Du, that he was lauding Vascepa and buying. He stated that he had "most of his wad tied up". I think I remember him best for saying that V would sell itself and that it would be stupid for Amarin to sell itself for less than $100 per share. Kinda like BB.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154234083
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154357575
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154577532
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154675359
Happy Thanksgiving to You and the Board and may our luck change.
Some days, I too would just like to wake up to selling the whole shebang at 10 and get on with what is remaining of life after wasting so many years with this.
But I have to say I have a different recollection of JL. Of course back in those days he was a prolific poster here so it is possible that he had one post out of hundreds where he wanted to throw in the towel, but you can see from these posts, just before and after Du, that he was lauding Vascepa and buying. He stated that he had "most of his wad tied up". I think I remember him best for saying that V would sell itself and that it would be stupid for Amarin to sell itself for less than $100 per share. Kinda like BB.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154234083
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154357575
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154577532
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154675359
Happy Thanksgiving to You and the Board and may our luck change.
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
